Schedule 13D ownership disclosure
POINT BIOPHARMA GLOBAL INC
Security class unavailable · CUSIP: 730541109
Event date: 2022-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.7400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-121236
- Form type
- SC 13D
- Filer
- POINT Biopharma Global Inc.
- CIK
- CIK 1811764
- Filed
- Nov 22, 2022
- Reporting period
- Nov 17, 2022
- Description
- Schedule 13D beneficial ownership